Cardiovascular diseases
Thesis
Lipoproteins and Hyperlipoproteinemia: Links to Gout
Gout and cardiovascular disease are both complex and multi-factorial with genetic predisposition and environmental triggers. Not only do both have high co-morbidity with other metabolic conditions, gout patients have high risk for cardiovascular events. Māori and Pacific populations have high risk for both gout and cardiovascular disease. The general aim of this study was to...
Thesis
The Mechanisms of Neuroprotection by Melatonin in Cerebral Ischaemia Reperfusion
Stroke is a major cause of death and the highest cause of morbidity worldwide. In NZ, the elderly and Maori and Pacific Island ethnicities are most affected. With failure of many neuroprotectant agents, current clinical therapy is limited to the use of thrombolytics to treat ischaemic stroke. Inflammation-dependent neurodegeneration occurs over a prolonged period after...
Thesis
An exploratory study of facilitators and barriers to the primary care management of those with high cardiovascular risk
Background: In 2003 the New Zealand Guidelines on the screening and management of patients for cardiovascular risk were published, with a revised handbook for primary healthcare staff updated in 2009. Several studies however have identified a significant gap between the guideline recommendations and current practice.
Report
Health care expenditure on cardiovascular diseases 2000-01
Presents summary data of allocated health expenditure collected by the Australian Institute of Health and Welfare. Introduction Cardiovascular diseases are Australia’s largest health problem, accounting for 50,294 deaths in 2002 and affecting 3.67 million Australians in 2001 (AIHW 2004b). In 1998, 1.1 million Australians had disabling conditions associated with cardiovascular diseases. Cardiovascular diseases are the...